London, United Kingdom

Richard James Mitter

This inventor holds 1 USPTO granted patent. Top assignee: Ares Trading S.a.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard James Mitter. Retrieved from https://idiyas.com/inventor/richard-james-mitter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard James Mitter: Innovator in Metalloprotease Proteins

Introduction

Richard James Mitter is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly through his work on metalloprotease proteins. His innovative approach has led to advancements in the diagnosis, prevention, and treatment of various diseases.

Latest Patents

Richard holds a patent for metalloprotease proteins, specifically identified as INSP005 and INSP005. This invention relates to secreted proteins that are members of the metalloprotease family. The patent emphasizes the use of these proteins and the nucleic acid sequences from the encoding genes in medical applications.

Career Highlights

Richard is associated with Ares Trading S.a., where he applies his expertise in biochemistry and protein research. His work has garnered attention for its potential impact on healthcare and disease management.

Collaborations

Richard has collaborated with notable colleagues, including Richard Fagan and Christopher Benjamin Phelps. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Richard James Mitter's contributions to the field of metalloprotease proteins exemplify the importance of innovation in medical science. His work not only advances our understanding of proteins but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…